New neurospinal scaffold system unveiled at AANS
InVivo Therapeutics has showcased a new investigational device for spinal cord injury patients at the 83rd American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in Washington, DC.
InVivo’s Neuro-Spinal Scaffold is an investigational bioresorbable polymer scaffold that can be implanted within a spinal cord contusion to provide structural support for spared spinal tissue. The supportive matrix is composed of two biocompatible and bioresorbable polymers cast to form a highly porous scaffold that is conducive to cellular attachment and neurite outgrowth and facilitates endogenous repair processes. It is intended to mitigate tissue damage from critical pathophysiological events occurring during the acute spinal cord injury phase, such as increase in tissue pressure, haemorrhage or oedema. A pilot trial is currently underway with subjects with acute spinal cord injury.
At the AANS meeting, details on the intraoperative videos from the first two subjects enrolled in the trial were given; intraoperative videos evaluating surgical implantation of the device into a porcine model of acute spinal cord injury were also presented.
The Neuro-Spinal Scaffold is one of 25 recipients of the 2015 Becker’s Healthcare Spine Device Awards. The awards, which recognise “both ‘tried-and-true’ devices as well as new promising innovations”, are determined by the editorial staff of Becker’s Spine Review and vetted by a panel of industry experts.
Source: Orthopedics This Week and www.beckersspine.com
